Tomorrow, our Senior Director of CAR-T Operations, Sarah Snykers, will provide the chairperson’s opening remarks at the #CHIBioprocessingSummit Europe in Barcelona. Don’t miss Sarah’s case study on expanding our #CARTCellTherapy footprint worldwide on March 19 at 8:25 a.m. CET! See the full agenda: https://lnkd.in/eBAfS7q #CART #CellTherapy
About us
Legend Biotech is a global, commercial-stage biotechnology company developing and manufacturing novel therapies. We explore and apply innovative technologies to deliver cutting-edge options for patients around the world. Our corporate headquarters is located in Somerset, NJ, and our manufacturing footprint includes facilities in the United States, China and the Belgium.
- Website
-
https://legendbiotech.com/
External link for Legend Biotech
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Somerset, New Jersey
- Type
- Public Company
- Specialties
- R&D, Cell Therapy, CAR-T, CAR-T Manufacturing, Biotechnology, and Pharmaceuticals
Locations
Employees at Legend Biotech
-
Frederik Buysse
-
Kathy Rosseel
(International) HR Manager - HR Director - Senior Human Resources Business Partner
-
Senthil Arumugam, MBA
Director of IT - Head of Data & AI and Application Development | Certified Databricks Azure Platform Architect | Commercial Insights | Data…
-
Yuhong Qiu
Updates
-
It's #MyelomaMonday, and we're celebrating the Multiple Myeloma Research Foundation - MMRF for their relentless pursuit of a cure. The MMRF is driving innovative research, accelerating the development of more personalized treatment approaches, and working tirelessly to improve the lives of #Myeloma patients. Explore their vital contributions: https://themmrf.org/ #MultipleMyelomaMonth #MultipleMyelomaAwarenessMonth #MultipleMyeloma #BloodCancer
-
-
Our Corporate Controller and Executive Director, Michael J. Clark, CPA, and ESG Controller, Sarah M. Stiff, are traveling to Philly next week for the Life Sciences Accounting & Reporting Congress! If you’re attending, don’t miss Sarah’s discussion about #ESG and the mechanics for accurate reporting on March 18 at 2:05 p.m. ET and Michael’s executive think tank on operational excellence on March 19 at 4:55 p.m. ET. Michael will also close the conference with a collaborative forum on March 20 at 3:20 p.m. ET.
-
-
#LegendNews: Today, we released our 2024 Q4 and Full-Year financial results. Our Interim Chief Financial Officer, Jessie Yeung, shares her thoughts. Read the highlights here: https://lnkd.in/eqZ4XhkA #WeAreLegend #FinancialResults
-
-
Happy #MyelomaMonday! This week, we’re highlighting International Myeloma Foundation (IMF), a global leader in #myeloma research, education, and patient support. From funding groundbreaking research to providing comprehensive resources for patients and families, the IMF is at the forefront of the fight against myeloma. Discover their impactful work: https://www.myeloma.org/ #MyelomaActionMonth #MultipleMyelomaMonth #MultipleMyeloma #MultipleMyelomaAwarenessMonth #BloodCancer
-
-
Tomorrow is #InternationalWomensDay. 🙌 Let’s #AccelerateAction and recognize the incredible women making a difference in science and medicine, including our LEGENDary team of talented and passionate women developing innovative #CellTherapies for patients with #Cancer. We admire your passion, dedication, and valuable contributions to the field. #IWD2025 #WomenInScience
-
-
If you’re attending the 6th Annual Supply Chain & Logistics for Cell & Gene Therapies Summit in Boston, catch our Director, Supply Chain Europe, Joyce C., on day one! She’ll participate in the panel discussion on improving supply chain communications at 9:30 a.m. ET and share valuable insights on commercial-scale #CARTCellTherapy supply planning at 1:40 p.m. ET. Don’t miss these opportunities to explore the critical role of #SupplyChain management in bringing transformative cell therapies to patients! More here: https://lnkd.in/dMCFvyug #CART #CellTherapy
-
-
This #MultipleMyelomaMonth, we’re saluting our patient advocacy partners! To begin, The Leukemia & Lymphoma Society just released a mini docuseries, “A Path of Hope and Healing,” where Maurice, a #MultipleMyeloma patient, shares how advancements in #CellTherapy transformed his life. Watch this in-depth video to learn more about his treatment: https://lnkd.in/ebMT29dU #MultipleMyelomaAwarenessMonth #CART
-
#ICYMI, Legend is looking for #LabTechnicians, #ProductionOperators, #QualitySpecialists, and #Engineers in Ghent, Belgium, who are ready to be part of the future of #CellTherapy. 3/5 – Bioscience Engineering Career Event | ICC, Ghent 3/20 – Jobhappening Howest | Kortrijk Xpo 3/27 – Interuniversity Job Market for Young Researchers - afstudeerbeurs | Flanders Expo, Ghent Don’t miss this exciting opportunity to work in one of our state-of-the-art facilities, where you can help develop groundbreaking therapies that make a real difference for patients. Learn about our open positions: https://lnkd.in/e-rXFgQq #JobFair #NowHiring #Biotech #JobOpening #Career #ApplyNow #JoinOurTeam #CART
-
-
As we celebrate the three-year anniversary of the US FDA’s approval of our #CellTherapy for the treatment of #MultipleMyeloma, members of our leadership team gathered to reflect on our progress to date. After many years of development, our cell therapy is forging the path to “CURE.” Having infused more than 5,000 patients, we are committed to setting ambitious goals toward one-day #EliminatingCancer. Our #LEGENDary team is determined to continuously push the boundaries of what’s possible!
-
Similar pages
Stock
LEGN
NASDAQ
20 minutes delay
$37.88
-0.06 (-0.158%)
- Open
- 38.14
- Low
- 37.31
- High
- 38.25
Data from Refinitiv
See more info on